-
Much mobile potential remains untapped
WHAT IT MEANS AND WHY IT'S IMPORTANT — William Gibson, the science fiction author famous for being a key founder of the cyberpunk literary movement, once wrote, "The future is already here. It just hasn't been evenly distributed yet." That's especially true when considering the relatively slow adoption of mobile technology by retailers despite the buzz surrounding it and its enormous potential.
-
FDA approves Lannett tension headache drug
PHILADELPHIA — The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.
Lannett announced the approval of butalbital, acetaminophen and caffeine tablets in the 50-mg/325-mg/40-mg strength. the drug is a generic version of Watson Pharmaceuticals' Fioricet.
Branded and generic versions of the drug had sales of $30 million during the 12-month period ended in July, including $15 million for branded Fioricet. Lannett plans to start shipping its version next month, the company said.